POTENTIAL MECHANISM-BASED TYROSINE KINASE INHIBITORS .2. DESIGN AND SYNTHESIS OF PEPTIDES CONTAINING HETEROCYCLIC TYROSINE ANALOGS

被引:5
作者
ANDREWS, DM
GREGORIOU, M
PAGE, TCM
PEACH, JM
PRATT, AJ
机构
[1] DYSON PERRINS LAB, OXFORD OX1 3QY, ENGLAND
[2] DEPT BIOCHEM, MOLEC BIOPHYS LAB, OXFORD, ENGLAND
[3] OXFORD CTR MOLEC SCI, OXFORD OX1 3QY, ENGLAND
[4] GLAXO RES & DEV, MED CHEM 2, GREENFORD UB6 0HE, MIDDX, ENGLAND
来源
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1 | 1995年 / 11期
关键词
D O I
10.1039/p19950001335
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The Fmoc derivatives of two homochiral tyrosine analogues, a pyridine N-oxide and a pyridone, have been prepared in high stereochemical purity. Solid-phase synthesis has been used to prepare a decapeptide substrate for the tyrosine kinase domain of epidermal growth factor. Two decapeptides, which incorporate the tyrosine analogues in place of tyrosine, and thereby have the potential to act as mechanism-based inhibitors of epidermal growth factor tyrosine kinase, have been synthesised and found to inhibit the aforementioned kinase.
引用
收藏
页码:1335 / 1340
页数:6
相关论文
共 21 条
[1]  
Andrews D.M., Page T.C., Peach J.M., Pratt A.J., J. Chetn. Soc, Perkin Trans, 1, (1995)
[2]  
Yarden Y., Ullrich A., Ann. Rev. Biochem, 57, (1988)
[3]  
Egan S.E., Weinberg R.A., Nature, 365, (1993)
[4]  
Ennis Lippman Dickson M.E.R.B., Cancer Inv, 9, (1991)
[5]  
Walsh C.T., Tetrahedron, 38, (1982)
[6]  
Silverman, Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology, 1, (1988)
[7]  
This Work was Reported in Part at the 4Th RSC SCI Joint Meeting on Heterocyclic Chemistry, (1994)
[8]  
Seaton D.R., Gelb M.H., Abeles R.H., Biochemistry, 24, (1985)
[9]  
Berson Cohen T., J. Am. Chetn. Soc, 78, (1956)
[10]  
Kornberg A., Baker T.A., DNA Replication, 2Nd Edn., W. H. Freeman & Co., New York, (1992)